• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低分子量鱼精蛋白-siRNA 偶联物的改进合成方法。

Improved method for synthesis of low molecular weight protamine-siRNA conjugate.

作者信息

Yu Zhili, Ye Junxiao, Pei Xing, Sun Lu, Liu Ergang, Wang Jianxin, Huang Yongzhuo, Lee Seung Jin, He Huining

机构信息

Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.

College of Pharmacy, Tsinghua University, Beijing 100084, China.

出版信息

Acta Pharm Sin B. 2018 Jan;8(1):116-126. doi: 10.1016/j.apsb.2017.11.011. Epub 2017 Dec 19.

DOI:10.1016/j.apsb.2017.11.011
PMID:29872628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5985694/
Abstract

RNAi technology has aroused wide public interest due to its high efficiency and specificity to treat multiple types of diseases. However, the effective delivery of siRNA remains a challenge due to its large molecular weight and strong anionic charge. Considering their remarkable functions and features that are often desired in drug delivery carriers, biomimetic systems for siRNA delivery become an effective and promising strategy. Based on this, covalent attachment of synthetic cell penetrating peptides (CPP) to siRNA has become of great interest. We developed a monomeric covalent conjugate of low molecular weight protamine (LMWP, a well-established CPP) and siRNA a cytosol-cleavable disulfide linkage using PEG as a crosslinker. Results showed that the conjugates didn't generate coagulation, and exhibited much better RNAi potency and intracellular delivery compared with the conventional charge-complexed CPP/siRNA aggregates. Three different synthetic and purification methods were compared in order to optimize synthesis efficiency and product yield. The methodology using hetero-bifunctional NHS-PEG-OPSS as a crosslinker to synthesize LMWP-siRNA simplified the synthesis and purification process and produced the highest yield. These results pave the way towards siRNA biomimetic delivery and future clinical translation.

摘要

RNA干扰(RNAi)技术因其高效性和特异性可用于治疗多种疾病,已引起广泛的公众关注。然而,由于小干扰RNA(siRNA)分子量较大且带强负电荷,其有效递送仍然是一个挑战。考虑到它们在药物递送载体中通常所需的显著功能和特性,用于siRNA递送的仿生系统成为一种有效且有前景的策略。基于此,将合成的细胞穿透肽(CPP)共价连接到siRNA上已引起了极大的关注。我们使用聚乙二醇(PEG)作为交联剂,开发了一种低分子量鱼精蛋白(LMWP,一种成熟的CPP)与siRNA的单体共价缀合物,通过可在细胞质中裂解的二硫键连接。结果表明,与传统的电荷复合CPP/siRNA聚集体相比,该缀合物不会产生凝聚,并且表现出更好的RNA干扰活性和细胞内递送能力。为了优化合成效率和产物收率,比较了三种不同的合成和纯化方法。使用异双功能N-羟基琥珀酰亚胺-聚乙二醇-邻吡啶二硫醚(NHS-PEG-OPSS)作为交联剂合成LMWP-siRNA的方法简化了合成和纯化过程,并产生了最高的收率。这些结果为siRNA仿生递送和未来的临床转化铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/817ea2976eba/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/bb3772be69f3/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/2318ad0fb85e/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/43624ad2b842/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/e006de245dba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/7a4e5a287451/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/125ed45d03ee/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/817ea2976eba/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/bb3772be69f3/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/2318ad0fb85e/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/43624ad2b842/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/e006de245dba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/7a4e5a287451/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/125ed45d03ee/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dcb/5985694/817ea2976eba/gr5.jpg

相似文献

1
Improved method for synthesis of low molecular weight protamine-siRNA conjugate.低分子量鱼精蛋白-siRNA 偶联物的改进合成方法。
Acta Pharm Sin B. 2018 Jan;8(1):116-126. doi: 10.1016/j.apsb.2017.11.011. Epub 2017 Dec 19.
2
High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.用于有效胞质递送小干扰RNA的单体低分子量富含脯氨酸的蛋白质(CPP)-小干扰RNA共价缀合物的高产率合成
Theranostics. 2017 Jun 25;7(9):2495-2508. doi: 10.7150/thno.19863. eCollection 2017.
3
The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption.利用低分子量鱼精蛋白化学嵌合体增强单体胰岛素的肠道吸收。
Biomaterials. 2013 Oct;34(31):7733-43. doi: 10.1016/j.biomaterials.2013.06.047. Epub 2013 Jul 14.
4
Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide.低分子量鱼精蛋白(LMWP):一种无毒的鱼精蛋白替代品和有效的细胞穿透肽。
J Control Release. 2014 Nov 10;193:63-73. doi: 10.1016/j.jconrel.2014.05.056. Epub 2014 Jun 3.
5
Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA.抗体-siRNA 偶联物(ARCs)使用多功能肽作为肿瘤酶可切割连接子介导 siRNA 的有效细胞内递送。
Int J Pharm. 2021 Sep 5;606:120940. doi: 10.1016/j.ijpharm.2021.120940. Epub 2021 Jul 24.
6
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.利用细胞穿透肽和低分子量鱼精蛋白进行 siRNA 的系统传递。
Biomaterials. 2010 Feb;31(6):1429-43. doi: 10.1016/j.biomaterials.2009.11.001. Epub 2009 Dec 1.
7
Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.低分子量鱼精蛋白修饰的 PLGA 纳米粒克服耐药性乳腺癌。
J Control Release. 2014 Oct 28;192:47-56. doi: 10.1016/j.jconrel.2014.06.051. Epub 2014 Jul 6.
8
Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): preparation and characterization.低分子量鱼精蛋白(LMWP)作为无毒肝素/低分子量肝素解毒剂(I):制备与表征
AAPS PharmSci. 2001;3(3):E17. doi: 10.1208/ps030317.
9
Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.经鼻内给药后用于脑部递药的低分子量鱼精蛋白功能化纳米粒。
Biomaterials. 2011 Dec;32(36):9888-98. doi: 10.1016/j.biomaterials.2011.09.004. Epub 2011 Sep 19.
10
Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.利用新型细胞穿透肽-siRNA缀合物负载的纳米气泡和超声实现高效的siRNA递送
Ultrasound Med Biol. 2016 Jun;42(6):1362-74. doi: 10.1016/j.ultrasmedbio.2016.01.017.

引用本文的文献

1
Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB).细胞穿透及靶向肽递送系统作为增强跨血脑屏障(BBB)递送的潜在药物载体
Pharmaceutics. 2023 Jul 21;15(7):1999. doi: 10.3390/pharmaceutics15071999.
2
A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future.基于蛋白质和肽的化学偶联物综述:过去、现在与未来
Pharmaceutics. 2023 Feb 10;15(2):600. doi: 10.3390/pharmaceutics15020600.
3
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells.

本文引用的文献

1
High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.用于有效胞质递送小干扰RNA的单体低分子量富含脯氨酸的蛋白质(CPP)-小干扰RNA共价缀合物的高产率合成
Theranostics. 2017 Jun 25;7(9):2495-2508. doi: 10.7150/thno.19863. eCollection 2017.
2
Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.使用具有双pH响应和肿瘤靶向性的纳米载体进行全身siRNA递送,以抑制乳腺癌原位小鼠模型中的肿瘤生长和自发转移。
Theranostics. 2017 Jan 1;7(2):357-376. doi: 10.7150/thno.16855. eCollection 2017.
3
细胞穿透肽用于将mRNA递送至癌细胞的潜力
Pharmaceutics. 2022 Jun 15;14(6):1271. doi: 10.3390/pharmaceutics14061271.
4
Cell-Penetrating Peptides Delivering siRNAs: An Overview.细胞穿透肽介导的 siRNA 递送:概述。
Methods Mol Biol. 2021;2282:329-352. doi: 10.1007/978-1-0716-1298-9_18.
5
Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses.生成的SecPen_NY-ESO-1泛素脉冲树突状细胞癌症疫苗引发更强且特异的T细胞免疫反应。
Acta Pharm Sin B. 2021 Feb;11(2):476-487. doi: 10.1016/j.apsb.2020.08.004. Epub 2020 Aug 25.
6
Editorial for biomimetic nanoparticles for drug delivery.用于药物递送的仿生纳米颗粒编辑社论。
Acta Pharm Sin B. 2018 Jan;8(1):2-3. doi: 10.1016/j.apsb.2018.01.003. Epub 2018 Feb 3.
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer.
靶向ICAM-1、包裹Lcn2小干扰RNA的脂质体是三阴性乳腺癌的强效抗血管生成剂。
Theranostics. 2016 Jan 1;6(1):1-13. doi: 10.7150/thno.12167. eCollection 2016.
4
Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics.当前用于 RNA 治疗的基于小干扰 RNA(siRNA)的临床前缀合系统。
Adv Drug Deliv Rev. 2016 Sep 1;104:78-92. doi: 10.1016/j.addr.2015.10.009. Epub 2015 Oct 27.
5
Reductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo.尺寸、形状均一且组成可调的还原性响应水凝胶纳米颗粒用于体内系统性siRNA递送
Mol Pharm. 2015 Oct 5;12(10):3518-3526. doi: 10.1021/acs.molpharmaceut.5b00054. Epub 2015 Sep 4.
6
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery.多功能、刺激响应型纳米颗粒给药系统。
Nat Rev Drug Discov. 2014 Nov;13(11):813-27. doi: 10.1038/nrd4333. Epub 2014 Oct 7.
7
Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer.通过使用精氨酸修饰的两亲性树状聚合物增强细胞摄取来促进 siRNA 的传递。
Nanoscale. 2015 Mar 7;7(9):3867-75. doi: 10.1039/c4nr04759a.
8
PEG - a versatile conjugating ligand for drugs and drug delivery systems.聚乙二醇 - 一种多功能的药物和药物传递系统连接配体。
J Control Release. 2014 Oct 28;192:67-81. doi: 10.1016/j.jconrel.2014.06.046. Epub 2014 Jul 2.
9
Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide.低分子量鱼精蛋白(LMWP):一种无毒的鱼精蛋白替代品和有效的细胞穿透肽。
J Control Release. 2014 Nov 10;193:63-73. doi: 10.1016/j.jconrel.2014.05.056. Epub 2014 Jun 3.
10
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.CTLA4适配体将STAT3小干扰RNA递送至肿瘤相关T细胞和恶性T细胞。
J Clin Invest. 2014 Jul;124(7):2977-87. doi: 10.1172/JCI73174. Epub 2014 Jun 2.